ARCHIVES

Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.

This article is from The Cancer Letter archive.

Vol. 28 No. 04 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

Five Investigations Probe NIH Radiation Contamination

November 17, 1995

Nominations Open for Bristol-Myers $25,000

September 29, 1978

Charges Against CC Probed; Most Found Invalid

March 31, 1978

In Brief: NCI Recieves Two Proposals For Antineoplaston Trials, None For Children; Stubble Elected To NAS

June 19, 1992

60 Minutes Report “Deception at Duke” Wins Peabody Award

March 29, 2013

NCI Moves To Suspend Researcher Amid Charges Contractor Made Mortgage And Other Payments

May 4, 1990